Assessing Tolerability of Avonex Intramuscular Injections
| Status: | Completed |
|---|---|
| Conditions: | Neurology, Multiple Sclerosis |
| Therapuetic Areas: | Neurology, Other |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 4/21/2016 |
| Start Date: | May 2012 |
| End Date: | February 2014 |
Assessing Tolerability of Avonex Intramuscular Injections With a 25 Gauge Needle Versus 30 Gauge Needle
The purpose of this study is to evaluate patients' views when injecting Avonex
intramuscularly.
intramuscularly.
Inclusion Criteria:
- Between 18 - 65 years of age;
- Confirmed diagnosis of Relapsing Remitting Multiple Sclerosis;
- Currently being treated with Avonex® for at least 90 days;
- Using 25 gauge needles for injection of Avonex® for at least 90 days;
- Willing and able to complete study questionnaires; and
- Provided informed consent to participate in this study
Exclusion Criteria:
- Diagnosis of Progressive Multiple Sclerosis;
- History of recent illness or infection;
- History of allergic reaction to Avonex®;
- Any prior usage of a 30 gauge needle for administration of Avonex®;
- Concurrent treatment with other immunomodulating therapies;
- Pregnant or planning on becoming pregnant;
- Nursing mothers; and
- Unable to complete the requirements of the study
We found this trial at
1
site
Click here to add this to my saved trials
